Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05524948 · ClinicalTrials.gov registry record · NA
A Clinical Study to Examine the Effects of an Experimental Toothpaste Compared to a Regular Fluoride Toothpaste on Breath Odor in a Population With Gingivitis
A NA study of Halitosis, sponsored by HALEON.
- Completed
- Registry status
- NA
- Development phase
- 104
- Enrollment target
- 1
- Study location
NCT05524948: Completed NA study of Halitosis, sponsored by HALEON.
NCT05524948 is a NA study of Halitosis that has completed, run by HALEON. The registered enrollment target is 104 participants, above the 24-participant average among 3 other Halitosis trials with a reported enrollment target (333% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05524948, a NA study of Halitosis, has completed, sponsored by HALEON.
- COMPLETED
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate the efficacy of an experimental dentifrice, containing 0.454 percent (%) stannous fluoride and 0.3% zinc chloride, to reduce oral malodor, compared to a marketed regular fluoride dentifrice after 3 weeks twice daily brushing in a population of clinically diagnosed gingivitis.
Primary Outcome
An organoleptic assessment was used to evaluate the oral odor and defined as a method that measures the strength of target odor and expresses the value in terms of a score with reference to a pre-defined organoleptic scale. The assessors evaluated the oral odor and scored from 0 (lowest score) to 5 (highest score), where 0= No appreciable odor, 1= Barely noticeable odor, 2= Slight but clearly noticeable odor, 3= Moderate odor, 4= Strong odor, 5= Extremely foul odor. Lower score indicates improve
Conditions Studied
Interventions
- OTHER Experimental Dentifrice
- OTHER Reference Dentifrice
Study Locations (1)
Indiana
- Salus Research Inc. - Fort Wayne
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2022-09-26 |
| Est. Completion | 2022-10-27 |
| Phase | NA |
What the finished NCT05524948 record still lists
NCT05524948 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, above the 24-participant average among 3 other Halitosis trials with a reported enrollment target (333% higher).
The record links to 1 condition, with Halitosis appearing as the primary indexed condition, and to 2 interventions - of which Experimental Dentifrice is the first listed.
NCT05524948 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT05524948 about?
NCT05524948 is a clinical study titled "A Clinical Study to Examine the Effects of an Experimental Toothpaste Compared to a Regular Fluoride Toothpaste on Breath Odor in a Population With Gingivitis". The purpose of this study is to investigate the efficacy of an experimental dentifrice, containing 0.454 percent (%) stannous fluoride and 0.3% zinc chloride, to reduce oral malodor, compared to a marketed regular fluoride dentifrice after 3 weeks twice daily brushing in a population of clinically d...
What is the current status of trial NCT05524948?
This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2022-09-26. Estimated completion is 2022-10-27.
What conditions does trial NCT05524948 study?
This clinical trial studies the following conditions: Halitosis.
What interventions are being tested in trial NCT05524948?
The interventions under investigation include: Experimental Dentifrice (OTHER), Reference Dentifrice (OTHER).
Who is sponsoring clinical trial NCT05524948?
This trial is sponsored by HALEON, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05524948 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Halitosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI